Sermorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), consisting of the first 29 amino acids of the naturally occurring hormone. In research settings, Sermorelin is studied for its ability to stimulate the pituitary gland to release endogenous growth hormone, with investigations focused on growth hormone regulation, endocrine pathways, and age-related changes in hormone signaling.
Applications:
Studies on growth hormone release and regulation
Research into endocrine and metabolic pathways
Investigation of hypothalamic–pituitary signaling
Experimental models of age-related hormone decline
Important Notice:
It is supplied as a lyophilized powder for reconstitution and is intended for non-human research purposes only.